Distinct requirements for activation of NKT and NK cells during viral infection

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3676-3685

  Tyznik, Aaron J ^a   Verma, Shilpi ^a   Wang, Qiao ^a   Kronenberg, Mitchell ^a   Benedict, Chris A ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL COMMUNICATION; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-12; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MUROMEGALOVIRUS; NATURAL KILLER T-CELLS; RECEPTORS, CYTOKINE; VIRUS DISEASES;

EID: 84898645155     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300837     Document Type: Article

References (56)

1. Loewendorf, A., and C. A. Benedict. 2010. Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J. Intern. Med. 267: 483-501.
2. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045-1056.
3. Tyznik, A. J., E. Tupin, N. A. Nagarajan, M. J. Her, C. A. Benedict, and M. Kronenberg. 2008. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181: 4452-4456.
4. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
5. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
6. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
7. Wingender, G., P. Rogers, G. Batzer, M. S. Lee, D. Bai, B. Pei, A. Khurana, M. Kronenberg, and A. A. Horner. 2011. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J. Exp. Med. 208: 1151-1162.
8. Paget, C., T. Mallevaey, A. O. Speak, D. Torres, J. Fontaine, K. C. Sheehan, M. Capron, B. Ryffel, C. Faveeuw, M. Leite de Moraes, et al. 2007. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609.
9. Nagarajan, N. A., and M. Kronenberg. 2007. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178: 2706-2713.
10. Wesley, J. D., M. S. Tessmer, D. Chaukos, and L. Brossay. 2008. NK cell-like behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathog. 4: e1000106.
11. Cohen, N. R., R. V. Tatituri, A. Rivera, G. F. Watts, E. Y. Kim, A. Chiba, B. B. Fuchs, E. Mylonakis, G. S. Besra, S. M. Levitz, et al. 2011. Innate recognition of cell wall b-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe 10: 437-450.
12. Tyznik, A. J., E. Farber, E. Girardi, A. Birkholz, Y. Li, S. Chitale, R. So, P. Arora, A. Khurana, J. Wang, et al. 2011. Glycolipids that elicit IFN-g-biased responses from natural killer T cells. Chem. Biol. 18: 1620-1630.
13. Salazar-Mather, T. P., and K. L. Hokeness. 2006. Cytokine and chemokine networks: pathways to antiviral defense. Curr. Top. Microbiol. Immunol. 303: 29-46.
14. Pyzik, M., E. M. Gendron-Pontbriand, and S. M. Vidal. 2011. The impact of Ly49-NK cell-dependent recognition of MCMV infection on innate and adaptive immune responses. J. Biomed. Biotechnol. 2011: 641702.
15. Babić, M., A. Krmpotić, and S. Jonjić. 2011. All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends Mol. Med. 17: 677-685.
16. Scalzo, A. A., M. G. Brown, D. T. Chu, J. W. Heusel, W. M. Yokoyama, and C. A. Forbes. 1999. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics 49: 238-241.
17. Schneider, K., A. Loewendorf, C. De Trez, J. Fulton, A. Rhode, H. Shumway, S. Ha, G. Patterson, K. Pfeffer, S. A. Nedospasov, et al. 2008. Lymphotoxinmediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3: 67-76.
18. Shellam, G. R., J. E. Allan, J. M. Papadimitriou, and G. J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA 78: 5104-5108.
19. Dalod, M., T. Hamilton, R. Salomon, T. P. Salazar-Mather, S. C. Henry, J. D. Hamilton, and C. A. Biron. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197: 885-898.
20. Zucchini, N., G. Bessou, S. H. Robbins, L. Chasson, A. Raper, P. R. Crocker, and M. Dalod. 2008. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int. Immunol. 20: 45-56.
21. Swiecki, M., S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna. 2010. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33: 955-966.
22. Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101: 3516-3521.
23. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
24. Reddehase, M. J., F. Weiland, K. Munch, S. Jonjic, A. Luske, and U. H. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55: 264-273.
25. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.
26. Brigl, M., R. V. Tatituri, G. F. Watts, V. Bhowruth, E. A. Leadbetter, N. Barton, N. R. Cohen, F. F. Hsu, G. S. Besra, and M. B. Brenner. 2011. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208: 1163-1177.
27. Benedict, C. A., A. Loewendorf, Z. Garcia, B. R. Blazar, and E. M. Janssen. 2008. Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J. Immunol. 180: 4836-4847.
28. Miyagi, T., M. P. Gil, X. Wang, J. Louten, W. M. Chu, and C. A. Biron. 2007. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J. Exp. Med. 204: 2383-2396.
29. Pien, G. C., A. R. Satoskar, K. Takeda, S. Akira, and C. A. Biron. 2000. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J. Immunol. 165: 4787-4791.
30. Kastenmuller, W., P. Torabi-Parizi, N. Subramanian, T. Lämmermann, and R. N. Germain. 2012. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150: 1235-1248.
31. van Dommelen, S. L., H. A. Tabarias, M. J. Smyth, and M. A. Degli-Esposti. 2003. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77: 1877-1884.
32. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
33. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
34. Pyzik, M., B. Charbonneau, E. M. Gendron-Pontbriand, M. Babić, A. Krmpotić, S. Jonjić, and S. M. Vidal. 2011. Distinct MHC class I-dependent NK cellactivating receptors control cytomegalovirus infection in different mouse strains. J. Exp. Med. 208: 1105-1117.
35. Brown, M. G., and A. A. Scalzo. 2008. NK gene complex dynamics and selection for NK cell receptors. Semin. Immunol. 20: 361-368.
36. Banovic, T., M. Yanilla, R. Simmons, I. Robertson, W. A. Schroder, N. C. Raffelt, Y. A. Wilson, G. R. Hill, P. Hogan, and C. B. Nourse. 2011. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression. J. Infect. Dis. 204: 1893-1901.
37. Levy, O., J. S. Orange, P. Hibberd, S. Steinberg, P. LaRussa, A. Weinberg, S. B. Wilson, A. Shaulov, G. Fleisher, R. S. Geha, et al. 2003. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J. Infect. Dis. 188: 948-953.
38. Moll, M., S. K. Andersson, A. Smed-Sorensen, and J. K. Sandberg. 2010. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 116: 1876-1884.
39. Raftery, M. J., M. Hitzler, F. Winau, T. Giese, B. Plachter, S. H. E. Kaufmann, and G. Schönrich. 2008. Inhibition of CD1 antigen presentation by human cytomegalovirus. J. Virol. 82: 4308-4319.
40. Raftery, M. J., F. Winau, T. Giese, S. H. E. Kaufmann, U. E. Schaible, and G. Schönrich. 2008. Viral danger signals control CD1d de novo synthesis and NKT cell activation. Eur. J. Immunol. 38: 668-679.
41. Webb, T. J. R., R. A. Litavecz, M. A. Khan, W. J. Du, J. Gervay-Hague, G. J. Renukaradhya, and R. R. Brutkiewicz. 2006. Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules. Eur. J. Immunol. 36: 2595-2600.
42. Yuan, W. M., A. Dasgupta, and P. Cresswell. 2006. Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat. Immunol. 7: 835-842.
43. Brennan, P. J., R. V. Tatituri, M. Brigl, E. Y. Kim, A. Tuli, J. P. Sanderson, S. D. Gadola, F. F. Hsu, G. S. Besra, and M. B. Brenner. 2011. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat. Immunol. 12: 1202-1211.
44. Verma, S., Q. Wang, G. Chodaczek, and C. A. Benedict. 2013. Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus. J. Virol. 87: 6201-6210.
45. Vilarinho, S., K. Ogasawara, S. Nishimura, L. L. Lanier, and J. L. Baron. 2007. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc. Natl. Acad. Sci. USA 104: 18187-18192.
46. Arase, H., N. Arase, and T. Saito. 1996. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med. 183: 2391-2396.
47. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191: 1895-1903.
48. Krmpotic, A., M. Hasan, A. Loewendorf, T. Saulig, A. Halenius, T. Lenac, B. Polic, I. Bubic, A. Kriegeskorte, E. Pernjak-Pugel, et al. 2005. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201: 211-220.
49. Lodoen, M., K. Ogasawara, J. A. Hamerman, H. Arase, J. P. Houchins, E. S. Mocarski, and L. L. Lanier. 2003. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197: 1245-1253.
50. Velázquez, P., T. O. Cameron, Y. Kinjo, N. Nagarajan, M. Kronenberg, and M. L. Dustin. 2008. Cutting edge: activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. J. Immunol. 180: 2024-2028.
51. Andrews, D. M., A. A. Scalzo, W. M. Yokoyama, M. J. Smyth, and M. A. Degli-Esposti. 2003. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4: 175-181.
52. Andoniou, C. E., S. L. van Dommelen, V. Voigt, D. M. Andrews, G. Brizard, C. Asselin-Paturel, T. Delale, K. J. Stacey, G. Trinchieri, and M. A. Degli-Esposti. 2005. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6: 1011-1019.
53. Andrews, D. M., C. E. Andoniou, F. Granucci, P. Ricciardi-Castagnoli, and M. A. Degli-Esposti. 2001. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2: 1077-1084.
54. Robbins, S. H., T. Walzer, D. Dembe'lé, C. Thibault, A. Defays, G. Bessou, H. Xu, E. Vivier, M. Sellars, P. Pierre, et al. 2008. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9: R17.
55. Tupin, E., Y. Kinjo, and M. Kronenberg. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5: 405-417.
56. Xie, X. F., A. Dighe, P. Clark, P. Sabastian, S. Buss, and M. G. Brown. 2007. Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J. Virol. 81: 229-236.